Neural tube defects and deletions of 22q11

Robert Nickel, R. Ellen Magenis

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Recently we reported on three unrelated children with neural tube defects (NTDs) and deletion of 22q11. Two of these children have velo- cardio-facial syndrome and the third DiGeorge sequence. Thus, NTDs appear to be part of the clinical picture due to 22q11 deletion. To further explore this association and to clarify what findings should prompt testing for this deletion in individuals with NTDs, we have reviewed all patients in a large regional spina bifida clinic population. Two hundred ninety-five patients with NTDs were identified by chart review. Charts were reviewed for congenital heart defect, minor facial anomalies, thymic hypoplasia, cleft lip and/or palate, hypocalcemia, and a family history of a NTD, congenital heart defect, or cleft lip and/or palate. A total of 22 patients was identified with NTD and at least one more clinical trait and/or a positive family history. Sixteen children received cytogenetic and molecular testing including the three previously reported patients diagnosed with a 22q11 deletion. Results of cytogenetic and molecular studies of the remaining 13 patients were normal. Deletion of 22q11 is an infrequent cause of NTDs. We recommend testing for the 22q11 deletion in patients with a NTD and conotruncal heart defect. Testing should be considered in patients with a NTD who have a first degree relative with a conotruncal heart defect or have additional clinical findings of VCFS or DGS.

Original languageEnglish (US)
Pages (from-to)25-27
Number of pages3
JournalAmerican Journal of Medical Genetics
Volume66
Issue number1
DOIs
StatePublished - Dec 2 1996
Externally publishedYes

Fingerprint

Neural Tube Defects
DiGeorge Syndrome
Congenital Heart Defects
Cleft Lip
Cleft Palate
Cytogenetics
Spinal Dysraphism
Hypocalcemia

Keywords

  • cleft palate
  • congenital heart defect
  • conotruncal heart defect
  • deletion 22q11
  • DiGeorge sequence
  • meningomyelocele
  • neural tube defect
  • velo-cardio-facial syndrome

ASJC Scopus subject areas

  • Genetics(clinical)
  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology

Cite this

Neural tube defects and deletions of 22q11. / Nickel, Robert; Magenis, R. Ellen.

In: American Journal of Medical Genetics, Vol. 66, No. 1, 02.12.1996, p. 25-27.

Research output: Contribution to journalArticle

Nickel, Robert ; Magenis, R. Ellen. / Neural tube defects and deletions of 22q11. In: American Journal of Medical Genetics. 1996 ; Vol. 66, No. 1. pp. 25-27.
@article{b43a94ded97a41adb05d5c91a3981b06,
title = "Neural tube defects and deletions of 22q11",
abstract = "Recently we reported on three unrelated children with neural tube defects (NTDs) and deletion of 22q11. Two of these children have velo- cardio-facial syndrome and the third DiGeorge sequence. Thus, NTDs appear to be part of the clinical picture due to 22q11 deletion. To further explore this association and to clarify what findings should prompt testing for this deletion in individuals with NTDs, we have reviewed all patients in a large regional spina bifida clinic population. Two hundred ninety-five patients with NTDs were identified by chart review. Charts were reviewed for congenital heart defect, minor facial anomalies, thymic hypoplasia, cleft lip and/or palate, hypocalcemia, and a family history of a NTD, congenital heart defect, or cleft lip and/or palate. A total of 22 patients was identified with NTD and at least one more clinical trait and/or a positive family history. Sixteen children received cytogenetic and molecular testing including the three previously reported patients diagnosed with a 22q11 deletion. Results of cytogenetic and molecular studies of the remaining 13 patients were normal. Deletion of 22q11 is an infrequent cause of NTDs. We recommend testing for the 22q11 deletion in patients with a NTD and conotruncal heart defect. Testing should be considered in patients with a NTD who have a first degree relative with a conotruncal heart defect or have additional clinical findings of VCFS or DGS.",
keywords = "cleft palate, congenital heart defect, conotruncal heart defect, deletion 22q11, DiGeorge sequence, meningomyelocele, neural tube defect, velo-cardio-facial syndrome",
author = "Robert Nickel and Magenis, {R. Ellen}",
year = "1996",
month = "12",
day = "2",
doi = "10.1002/(SICI)1096-8628(19961202)66:1<25::AID-AJMG6>3.0.CO;2-V",
language = "English (US)",
volume = "66",
pages = "25--27",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Neural tube defects and deletions of 22q11

AU - Nickel, Robert

AU - Magenis, R. Ellen

PY - 1996/12/2

Y1 - 1996/12/2

N2 - Recently we reported on three unrelated children with neural tube defects (NTDs) and deletion of 22q11. Two of these children have velo- cardio-facial syndrome and the third DiGeorge sequence. Thus, NTDs appear to be part of the clinical picture due to 22q11 deletion. To further explore this association and to clarify what findings should prompt testing for this deletion in individuals with NTDs, we have reviewed all patients in a large regional spina bifida clinic population. Two hundred ninety-five patients with NTDs were identified by chart review. Charts were reviewed for congenital heart defect, minor facial anomalies, thymic hypoplasia, cleft lip and/or palate, hypocalcemia, and a family history of a NTD, congenital heart defect, or cleft lip and/or palate. A total of 22 patients was identified with NTD and at least one more clinical trait and/or a positive family history. Sixteen children received cytogenetic and molecular testing including the three previously reported patients diagnosed with a 22q11 deletion. Results of cytogenetic and molecular studies of the remaining 13 patients were normal. Deletion of 22q11 is an infrequent cause of NTDs. We recommend testing for the 22q11 deletion in patients with a NTD and conotruncal heart defect. Testing should be considered in patients with a NTD who have a first degree relative with a conotruncal heart defect or have additional clinical findings of VCFS or DGS.

AB - Recently we reported on three unrelated children with neural tube defects (NTDs) and deletion of 22q11. Two of these children have velo- cardio-facial syndrome and the third DiGeorge sequence. Thus, NTDs appear to be part of the clinical picture due to 22q11 deletion. To further explore this association and to clarify what findings should prompt testing for this deletion in individuals with NTDs, we have reviewed all patients in a large regional spina bifida clinic population. Two hundred ninety-five patients with NTDs were identified by chart review. Charts were reviewed for congenital heart defect, minor facial anomalies, thymic hypoplasia, cleft lip and/or palate, hypocalcemia, and a family history of a NTD, congenital heart defect, or cleft lip and/or palate. A total of 22 patients was identified with NTD and at least one more clinical trait and/or a positive family history. Sixteen children received cytogenetic and molecular testing including the three previously reported patients diagnosed with a 22q11 deletion. Results of cytogenetic and molecular studies of the remaining 13 patients were normal. Deletion of 22q11 is an infrequent cause of NTDs. We recommend testing for the 22q11 deletion in patients with a NTD and conotruncal heart defect. Testing should be considered in patients with a NTD who have a first degree relative with a conotruncal heart defect or have additional clinical findings of VCFS or DGS.

KW - cleft palate

KW - congenital heart defect

KW - conotruncal heart defect

KW - deletion 22q11

KW - DiGeorge sequence

KW - meningomyelocele

KW - neural tube defect

KW - velo-cardio-facial syndrome

UR - http://www.scopus.com/inward/record.url?scp=0029956830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029956830&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-8628(19961202)66:1<25::AID-AJMG6>3.0.CO;2-V

DO - 10.1002/(SICI)1096-8628(19961202)66:1<25::AID-AJMG6>3.0.CO;2-V

M3 - Article

C2 - 8957506

AN - SCOPUS:0029956830

VL - 66

SP - 25

EP - 27

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 1

ER -